Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemotherapy-Induced Cognitive Change and DNA Damage in Breast Cancer Survivors

NCT00496613 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT00496613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00496613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemotherapy-Induced Cognitive Change and DNA Damage in Breast Cancer Survivors
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
June 30, 2007
Completion date
April 18, 2022
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, long-term survivors